Protein detail

PDCD1

Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279)

Protein symbol
PDCD1
UniProt ID
EVMP score
0.25
Frequency
1
Transmembrane count
1
Protein classification
CD markersDisease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsTransporters
Basic Information
Protein Names
Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279)
Protein Class
CD markersDisease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsTransporters
Protein Function
  • Disease related genes
  • Human disease related genes:Immune system diseases:Other immune system diseases
  • Human disease related genes:Nervous system diseases:Other nervous and sensory system diseases
  • Predicted intracellular proteins
  • CD markers
  • Transporters:Accessory Factors Involved in Transport
  • Human disease related genes:Immune system diseases:Allergies and autoimmune diseases
  • FDA approved drug targets:Biotech drugs
Transmembrane
171..191; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
CD279hSLE1PD-1PD1SLEB2
Gene Description
Programmed cell death 1
Chromosome
2
Position
241849884-241858894
Frequency
1
EVMP Score
0.25
Fluorescence & Localization
Tissue Specificskeletal muscleCell SpecificColonocytesSingle-Nuclei Brain Specificastrocyte
Function & Pathway
Protein Function
  • Disease related genes
  • Human disease related genes:Immune system diseases:Other immune system diseases
  • Human disease related genes:Nervous system diseases:Other nervous and sensory system diseases
  • Predicted intracellular proteins
  • CD markers
  • Transporters:Accessory Factors Involved in Transport
  • Human disease related genes:Immune system diseases:Allergies and autoimmune diseases
  • FDA approved drug targets:Biotech drugs
Mediation Categories
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediation
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

42 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorCellPhoneDBNoYesNoYesNo
receptorreceptorGO_IntercellNoYesNoYesNo
receptorreceptorICELLNETNoYesNoYesNo
receptorreceptorCellChatDBNoYesNoYesNo
receptorreceptorCellTalkDBNoYesNoYesNo
receptorreceptorGuide2PharmaNoYesNoYesNo
receptorreceptorLRdbNoYesNoYesNo
checkpointreceptorICELLNETNoYesNoYesNo
checkpoint_b7receptorICELLNETNoYesNoYesNo
receptorreceptorOmniPathNoYesNoYesNo
Page 1 of 5Next

Regulatory Interaction Network

6 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
PDCD1Q15116PTN6P29350YesYesNoKEGG-MEDICUSWangSignaLink3TCRcuration_SignaLink3SignaLink3:11160222SignaLink3:15240681SignaLink3:15358536SignaLink3:23109003
PTN11Q06124PDCD1Q15116YesNoYesHINTSIGNORIntActIntAct:15240681SIGNOR:32437509HINT:32064351HINT:28046066HINT:15240681IntAct:28046066
PDCD1Q15116PTN11Q06124YesYesNoKEGG-MEDICUSHINTSignaLink3IntActTCRcuration_SignaLink3IntAct:15240681SignaLink3:11160222SignaLink3:15240681SignaLink3:23109003SignaLink3:15358536HINT:32064351HINT:28046066HINT:15240681IntAct:28046066
CDK1P06493PDCD1Q15116YesNoYesSIGNORSIGNOR:36104103
PD1L1Q9NZQ7PDCD1Q15116YesYesNoiTALKKEGG-MEDICUSICELLNETSIGNORHINTCellPhoneDB_CellinkerInnateDBDIPLit-BM-17CellChatDBscConnectHPRDWojtowicz2020IntActWangCellPhoneDBBioGRIDCellinkerGuide2PharmaCellTalkDBconnectomeDB2020LRdbInnateDB:18841514InnateDB:11015443IntAct:20587542HINT:26602187CellChatDB:23954143BioGRID:36657039HINT:36657039IntAct:23417675IntAct:21982860HINT:31802034LRdb:12889478HPRD:12719480Cellinker:26681673HINT:23417675Lit-BM-17:21982860Cellinker:31757674HINT:11015443SIGNOR:11015443HINT:12893276Cellinker:23954143HINT:21982860InnateDB:12893276HINT:27618663DIP:26602187HPRD:12893276connectomeDB2020:23954143HINT:20587542ICELLNET:23954143InnateDB:21422170
COMPLEX:P63208_Q13616_Q969H0PDCD1Q15116YesNoYesSIGNORSIGNOR:36104103

Protein Complex Composition

23 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
DDX51NOL8PDCD11URB1URB2WDR89O60287Q14146Q14690Q76FK4Q8N8A6Q96FK60:0:0:0:0:0hu.MAP2
EMG1MPGNPM1NPM3PDCD11PELP1RPP25LSCAF1SKIC3TEX10USP36O75607P06748P29372Q14690Q6PGP7Q8IZL8Q8N5L8Q92979Q9H7N4Q9NXF1Q9P2750:0:0:0:0:0:0:0:0:0:0hu.MAP
ATG16L1CCT2CCT3CCT4CCT6ACCT7IGBP1PDCD11PPP2CBPPP2R2APPP2R2CPPP2R2DPPP4CTCP1UBCP0CG48P17987P40227P49368P50991P60510P62714P63151P78318P78371Q14690Q66LE6Q676U5Q99832Q9Y2T41:1:1:1:1:1:1:1:1:1:1:1:1:1:1NetworkBlastCompleatCompleat:HC7649
PDCD10PXNP49023Q9BUL81:4PDBPDB:3rqePDB:3rqgPDB:3rqf
CEBPZDDX54NOC2LPDCD11Q03701Q14690Q8TDD1Q9Y3T90:0:0:0hu.MAP2
CEBPZMAK16NOC2LPDCD11Q03701Q14690Q9BXY0Q9Y3T90:0:0:0hu.MAP2
PDCD1PTPN11Q06124Q151162:2PDBPDB:6royPDB:6rozPDB:6r5g
PDCD1Q151164PDBPDB:8u32PDB:9hk1PDB:6jjpPDB:6j15PDB:5ggrPDB:7bxaPDB:8gy5PDB:7cu5PDB:5jxePDB:5b8cPDB:5ggsPDB:7wvmPDB:7cgwPDB:8as0
PDCD1RAB5IFSLC25A28Q15116Q96A46Q9BUV80:0:0hu.MAP2
PDCD1RAB5IFQ15116Q9BUV80:0hu.MAP2
Page 2 of 3PreviousNext

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry139277144
Sequence, Structure & Domains

Sequences

Length
288
Mass
31,647
Sequence
MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL

3D Structural Models

Helix
84..86; 115..117
Beta Strand
27..29; 36..38; 40..45; 46..48; 50..55; 59..61; 63..70; 72..74; 77..83; 87..90; 94..99; 103..112; 119..127; 129..131; 133..136; 140..145
3D Structure
NMR spectroscopy (2); X-ray crystallography (34)

Domain & Motif Annotations

Compositional Bias
278..288; Basic and acidic residues
Motif
221..226; ITIM motif; 247..251; ITSM motif
Domain (FT)
35..145; Ig-like V-type
Region
25..34; Nivolumab binding; 70..77; Interaction with CD274/PDCD1L1; 74..99; Pembrolizumab binding; 254..288; Disordered
Clinical Relevance